The Best of ASCO Meetings offer timely science and education from the world’s premier oncology event, the ASCO Annual Meeting, in a two-day program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that will directly improve patient care. The program features in-depth discussion and analysis of the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment. Expert faculty will place abstract findings into clinical context and discuss how the results may change the current standard of care. The Meetings’ smaller size allows for ample time for audience participation and attendee interaction.
2018 Best of ASCO General Accreditation Information
In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Society of Clinical Oncology designates this live activity for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA/NCCPA Credit Designation Statement – PAs
PAs may claim Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Maintenance of Certification
Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CE credits claimed for the activity. It is the CE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For more information, please visit ASCO University – Earn MOC Points.
With emerging educational and scientific advances, oncology is a field where patient care standards can change very quickly. Due to the high volume of literature and best practices information available, it is important that oncologists and other cancer care providers synthesize and digest the latest evidence-based information applicable to their practice/research setting.
In an effort to meet educational needs based on this rapid exchange of information, ASCO is committed to disseminating the latest scientific findings in oncology and practice-changing advances in cancer prevention, diagnosis, treatment, and survivorship.
The Best of ASCO Meetings are designed for U.S. and international physicians and researchers involved in multidisciplinary clinical cancer care including, but not limited to, medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists.
The Best of ASCO Meetings are designed for the oncology team; credit is offered for physicians, but all are encouraged to participate as they may be able to apply for credit through their own licensing organization.
Upon participation in this activity, attendees will be able to
- Examine scientific advances that further enhance knowledge of cancer biology and pathogenesis;
- Incorporate knowledge gained pertaining to advances in clinical cancer research into innovative management strategies and trail designs to improve patient outcomes;
- Review recent and emerging data from key studies in clinical cancer research;
- Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with cancer;
- Implement clinical and scientific strategies designed to improve the quality of cancer care, as appropriate;
- Effectively communicate with colleagues and with patients regarding advances in clinical oncology science;
- Identify and utilize tools for cancer risk assessment and risk reduction based on the best available evidence;
- Collaborate across different specialties and with all members of the patient care team to provide the most effective treatment for patients with cancer.
Unlabelled Usage Statement
The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Meeting Cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.